Blog

  • European Shares Edge Higher as Oil Prices Ease and Investors Monitor French Debt Risks: DAX, CAC, FTSE100

    European Shares Edge Higher as Oil Prices Ease and Investors Monitor French Debt Risks: DAX, CAC, FTSE100

    European equities posted modest gains on Tuesday as declining oil prices and the prospect of renewed diplomatic discussions between the United States and Iran supported market sentiment. Concerns over France’s public finances continued to weigh on the outlook for European assets.

    The pan-European STOXX 600 rose 0.15%, extending its advance to a second consecutive session after gaining 1% on Monday. The previous session marked the index’s largest daily increase since 2 July.

    Germany’s DAX, the UK’s FTSE 100 and Spain’s IBEX 35 were broadly unchanged.

    Brent crude futures edged lower following a 3% decline in the previous session, while investors monitored developments surrounding the United Nations General Assembly and a rise in the cost of insuring French government debt against default.

    STOXX 600 Extends Gains for Second Session

    The STOXX 600 advanced 0.15% on Tuesday, building on Monday’s 1% increase.

    The earlier gain was the benchmark’s largest single-session rise since 2 July.

    Other major European indices showed little movement, with Germany’s DAX, London’s FTSE 100 and Spain’s IBEX 35 trading broadly flat.

    The modest advance coincided with a further decline in oil prices, which can reduce input costs for some businesses.

    However, the impact of lower energy prices varies by industry, with energy producers potentially facing weaker revenues while energy-intensive companies may benefit from reduced costs.

    Brent Crude Extends Decline

    Brent crude futures edged lower on Tuesday after falling approximately 3% in the previous session.

    The decline followed reports of alternative arrangements for transporting oil from the Persian Gulf, including pipeline routes and transfers between vessels.

    These arrangements could help maintain shipments despite disruption risks associated with the Middle East conflict.

    Oil markets also responded to indications of possible diplomatic engagement between Washington and Tehran.

    US President Donald Trump said he was open to direct discussions with Iranian President Masoud Pezeshkian, who was travelling to New York for the United Nations General Assembly.

    The comments raised the possibility of further diplomatic contact, although the supplied report does not confirm that a meeting has been arranged or that an agreement is imminent.

    Middle East Diplomacy Remains in Focus

    Investors are monitoring diplomatic developments as world leaders gather in New York for the United Nations General Assembly.

    The possibility of talks between the United States and Iran has drawn attention because of the conflict’s implications for energy production and shipping.

    Reports that companies are using alternative transport arrangements in the Persian Gulf have also contributed to the easing of immediate supply concerns.

    The decline in crude prices suggests that some of the additional cost associated with geopolitical uncertainty has diminished.

    Nevertheless, the durability of the move will depend on subsequent developments in the conflict, shipping conditions and diplomatic negotiations.

    French Sovereign Debt Concerns Persist

    France remained a focus for investors despite the broader improvement in European equity markets.

    The cost of insuring French government debt against default, measured through credit default swaps (CDS), rose on Monday to its highest level since March 2020, according to Reuters.

    The increase reflected concerns over France’s fiscal outlook and political difficulties surrounding efforts to address its budget deficit.

    French government bonds, known as OATs, have underperformed comparable sovereign debt from several other major developed economies this year, according to the supplied report.

    Higher CDS spreads indicate an increase in the market price of protection against sovereign default. They do not, by themselves, establish that a default will occur.

    The developments have added to investor scrutiny of French government borrowing costs and the country’s longer-term fiscal position.

    Central Bank Policy Influences Market Expectations

    Monetary policy remained another consideration for European investors.

    The Federal Reserve raised interest rates the previous week, while European Central Bank President Christine Lagarde has reiterated that future policy decisions will depend on economic data.

    Investors are assessing the implications of interest rates remaining elevated alongside the outlook for corporate earnings.

    Higher government bond yields can affect equity valuations by increasing the returns available on lower-risk assets and raising financing costs for companies.

    The effect on individual markets will depend on the path of inflation, economic growth and future central bank decisions.

    Outlook

    European equities recorded a second consecutive session of gains as oil prices continued to decline and investors assessed the possibility of renewed US-Iran diplomatic engagement.

    The STOXX 600 advanced 0.15%, although several major national indices remained broadly unchanged.

    French fiscal concerns provided a contrasting influence, with sovereign default insurance costs reaching their highest level since March 2020.

    Developments in the Middle East, energy prices, French public finances and central bank policy will remain important factors for European markets as the final quarter approaches.

  • Eurozone Bond Yields Rise as Investors Assess French Debt Risks and Lower Oil Prices

    Eurozone Bond Yields Rise as Investors Assess French Debt Risks and Lower Oil Prices

    Eurozone government bond yields moved higher on Tuesday as investors assessed concerns over France’s public finances alongside an easing of energy market pressures linked to the Middle East conflict.

    Germany’s two-year government bond yield held broadly steady at 3.229%, while the benchmark 10-year Bund yield increased to 3.479%, recovering from its lowest level in more than a week.

    French government bonds remained a focus after the cost of insuring the country’s sovereign debt against default reached its highest level since March 2020. France’s 10-year bond yield rose to 4.502%, widening its spread over the equivalent German benchmark.

    Oil prices declined amid reports of alternative shipping arrangements in the Persian Gulf and indications of possible US-Iran diplomatic discussions. Investors were also awaiting comments from European Central Bank officials, including President Christine Lagarde.

    German Bond Yields Recover From Recent Lows

    Germany’s two-year Schatz yield was little changed at approximately 3.229% after a rally in short-dated government bonds over recent sessions.

    The benchmark 10-year Bund yield rose to 3.479%, moving away from its lowest level in more than a week.

    The increase in longer-term yields coincided with a tentative recovery in broader risk assets and an easing of concerns about energy supply disruptions.

    Bond yields move inversely to prices, meaning the increase in yields indicates a decline in the market value of the corresponding securities.

    Trading remained sensitive to developments in energy markets, sovereign debt and expectations for European Central Bank monetary policy.

    French Sovereign Debt Insurance Costs Reach Highest Level Since 2020

    The cost of insuring French government debt against default rose on Monday to its highest level since March 2020, according to the supplied market report.

    The increase in credit default swap (CDS) spreads indicated that investors were demanding greater compensation for exposure to French sovereign credit risk.

    Concerns centred on France’s fiscal outlook, persistent budget deficits and political uncertainty.

    Official projections cited in the report indicate that France’s public debt is expected to reach 119.3% of gross domestic product in 2026 and increase further to 121.7% in 2027.

    These figures are forecasts rather than confirmed debt outcomes.

    Investors have also been assessing the implications of credit rating downgrades and difficulties in securing parliamentary agreement on fiscal measures.

    French 10-Year Yield Climbs to 4.502%

    The yield on France’s benchmark 10-year government bond, known as an OAT, rose to 4.502% on Tuesday, recovering from a one-week low.

    The movement widened the yield difference between French and German 10-year government bonds.

    French 10-year yields have increased by more than 90 basis points since the beginning of 2026, according to the report, exceeding the increases recorded in comparable German and US government bonds.

    The relative rise in French yields reflects the additional compensation investors have demanded for holding the country’s debt.

    French government bonds have consequently underperformed comparable sovereign securities in the markets covered by the report.

    The higher borrowing costs come as France faces projections of a rising debt-to-GDP ratio.

    French Equities Lag Broader European Market

    France’s CAC 40 was broadly unchanged during Tuesday’s session.

    The index was also approximately flat for the year to date, compared with a gain of nearly 7% for the STOXX 600.

    The difference in performance provides additional context for investor concerns surrounding the French market, although equity returns are influenced by a range of factors beyond sovereign debt developments.

    The divergence between the two indices comes as investors continue to monitor France’s fiscal position and political outlook.

    Lower Oil Prices Ease Energy Market Concerns

    Brent crude futures extended their decline amid reports that shipping companies were using alternative pipeline and ship-to-ship arrangements to transport oil from the Persian Gulf.

    Comments from US President Donald Trump indicating openness to discussions with Iranian President Masoud Pezeshkian at the United Nations General Assembly also contributed to attention on possible diplomatic developments.

    Lower oil prices can reduce some of the immediate pressure on inflation expectations, although their broader impact depends on the duration and scale of the decline.

    Energy market developments remain relevant to European bond markets because changes in oil prices can affect inflation expectations and the outlook for monetary policy.

    ECB Commentary in Focus

    Investors were awaiting scheduled remarks from senior European Central Bank officials, including President Christine Lagarde.

    The market report identified the ECB’s recent interest rate increase to 2.50% as a key consideration for traders assessing the next stage of monetary policy.

    Investors were looking for indications of whether policymakers consider the current rate sufficient to contain medium-term inflation or see a need for further tightening.

    Persistent fiscal deficits in major eurozone economies were also among the factors under consideration.

    The direction of future interest rates remains dependent on inflation, economic activity and subsequent ECB decisions.

    Outlook

    Eurozone bond markets face competing influences from easing energy prices, monetary policy expectations and concerns about sovereign debt.

    French government bonds remain under scrutiny as investors assess projected increases in public debt and the country’s ability to address its fiscal deficit.

    German bond yields have recovered from recent lows, while the widening spread between French and German securities highlights differences in how investors are pricing sovereign risk.

    Further developments in oil markets, French fiscal policy and ECB communications will remain relevant to trading conditions.

  • Luxury Brands Face Slowing Demand as Milan and Paris Fashion Weeks Begin

    Luxury Brands Face Slowing Demand as Milan and Paris Fashion Weeks Begin

    Luxury fashion groups are preparing to present their latest collections in Milan and Paris against a backdrop of weaker consumer demand, pressure on profit margins and concerns about the impact of the Middle East conflict on spending.

    Investors are questioning the sector’s growth prospects as a sustained recovery remains uncertain. Higher inflation associated with the conflict is adding pressure to household budgets, while demand for some luxury products, including high-end handbags, had already weakened.

    Shares in Kering (EU:KER), the owner of Gucci, have surrendered the gains recorded since chief executive Luca de Meo took charge a year ago. LVMH (E:MC), the world’s largest luxury group, has fallen 37% since the beginning of 2026.

    Fashion weeks offer brands an opportunity to introduce new designs and attract customers, but the events also represent substantial investments at a time when companies face growing pressure to improve their financial performance.

    Luxury Sector Recovery Remains Uncertain

    Executives and industry advisers expect difficult trading conditions to persist as luxury brands contend with changing consumer behaviour and economic uncertainty.

    Diego della Valle, chairman of Tod’s, told reporters in Milan on Friday:

    “I believe this year and next year will likely be a holding period while the market stabilises and becomes more predictable again.”

    The comments reflect concerns that a recovery in luxury spending may take longer than previously anticipated.

    The Middle East conflict has added another source of uncertainty, with its inflationary effects putting additional pressure on consumers’ purchasing power.

    For luxury companies, the challenge is to maintain sales and profitability while continuing to invest in products, marketing and customer relationships.

    Fashion Shows Face Greater Financial Scrutiny

    Major luxury houses are under pressure to demonstrate that spending on fashion shows can translate into stronger demand.

    Industry experts estimate that staging a major runway presentation can cost as much as €10 million.

    The expense comes as companies invest in new collections and creative strategies to attract shoppers whose enthusiasm for certain luxury categories has diminished.

    Milan and Paris Fashion Weeks will provide an opportunity to assess how brands are responding through their latest designs and product positioning.

    However, the commercial impact of these collections will depend on customer demand after the presentations.

    Middle-Class Spending Declines as Competition Intensifies

    Research by Bain and other consultancies indicates that middle-class consumers have reduced their spending on luxury products.

    As a result, brands are competing more intensely for wealthy customers, increasing investment in stores, personalised services and exclusive experiences despite declining sales in parts of the sector.

    Federico Bazzani, a partner at Deloitte Advisory, told Reuters:

    “There is strong polarisation among brands: fewer than half are growing, while the rest are losing ground.”

    He said companies must reconsider how they justify their pricing.

    “Brands face a choice: either invest in innovation, customer experience and cultural relevance to justify their price positioning, or revise their pricing and accept lower margins.”

    The comments highlight the different approaches available to luxury groups as they respond to weaker demand.

    Pricing Strategies Come Under Pressure

    Luxury brands have increased prices substantially in recent years, but industry advisers say even wealthy customers are becoming more sensitive to whether products offer value for money.

    David Watts, a London-based luxury business adviser, said companies face difficult choices over pricing and production.

    “They don’t want to reduce prices because that says we were overcharging you, and it loses them margin, but they don’t want to reduce production because that’s going to hit revenue.”

    Lower prices could reduce profit margins and affect perceptions of exclusivity, while cutting production could limit sales.

    Companies must therefore balance their pricing strategies with efforts to attract customers through product development and service improvements.

    Prada (TG:PRP), which opens Milan Fashion Week with its runway show on Tuesday, has recently redesigned its flagship store in Milan to include private spaces for its highest-spending customers.

    The investment reflects the wider industry’s efforts to develop more personalised shopping experiences.

    Consumer Preferences Shift Towards Experiences and Wellbeing

    Some industry executives believe changing spending priorities could delay a recovery in traditional luxury categories.

    Renzo Rosso, chairman of OTB, the owner of Diesel, said at a conference in Milan on Monday:

    “Consumers are changing.”

    He noted that shoppers are increasingly directing spending towards wellness, health and longevity, as well as hotels and restaurants.

    These preferences could intensify competition for discretionary spending, particularly if consumers choose experiences over fashion accessories.

    Rosso does not expect an imminent recovery in the luxury sector.

    His assessment adds to concerns that the industry’s challenges extend beyond the immediate effects of inflation and geopolitical uncertainty.

    Milan and Paris Fashion Weeks Put New Collections in Focus

    Prada is scheduled to open Milan Fashion Week on Tuesday.

    Gucci, Dolce & Gabbana and Giorgio Armani will also present their latest collections during the week.

    Paris Fashion Week begins on 28 September, with Dior (EU:CDI) and Louis Vuitton, both part of LVMH, among the major brands scheduled to show.

    Chanel will present its spring/summer 2027 collection on 5 October.

    The company has outperformed some competitors, supported by new designs from creative director Matthieu Blazy, according to the supplied report.

    The forthcoming presentations will offer an indication of how luxury houses are adapting their collections and marketing strategies to changing consumer preferences.

    Outlook

    The luxury industry faces a combination of weaker demand, pressure on pricing and uncertainty surrounding the economic consequences of the Middle East conflict.

    Research indicating reduced spending among middle-class consumers suggests that competition for wealthy customers could remain intense.

    Brands are responding through investment in new collections, flagship stores and exclusive experiences, while some executives expect the market to require additional time to stabilise.

    Milan and Paris Fashion Weeks will provide a platform for these strategies, although their effect on sales and profitability will become clearer only as the new collections reach customers.

  • FTSE 100 Edges Higher as UK Borrowing Reaches £18.3 Billion in August

    FTSE 100 Edges Higher as UK Borrowing Reaches £18.3 Billion in August

    The FTSE 100 edged higher on Tuesday as investors assessed UK public borrowing figures, developments in the Middle East and a series of corporate earnings announcements.

    The London benchmark was up 0.12% at 07:10 GMT, while Germany’s DAX declined 0.09% and France’s CAC 40 gained 0.04%. Sterling was unchanged against the US dollar at $1.3367.

    Figures from the Office for National Statistics (ONS) showed that UK public sector borrowing reached £18.3 billion in August, exceeding the Office for Budget Responsibility’s (OBR) forecast by £3.5 billion.

    Oil prices advanced amid continuing Middle East tensions, while gold declined. In UK company news, Kingfisher raised its full-year guidance, Smiths Group reported operating profit ahead of forecasts, and M&C Saatchi recorded a decline in first-half operating profit.

    UK Borrowing Exceeds OBR Forecast

    UK public sector borrowing reached £18.3 billion in August, according to figures reported by the ONS.

    The figure was £3.5 billion above the OBR’s forecast and represented the highest borrowing recorded for August outside the pandemic period.

    Debt interest payments reached £8.8 billion for the month, while cumulative borrowing for the financial year to August totalled £77.3 billion.

    That was £8.1 billion above the OBR’s March projection.

    The figures added to scrutiny of the UK’s public finances ahead of the forthcoming Budget.

    KPMG’s September outlook estimated that the Chancellor’s fiscal headroom had narrowed to approximately £12 billion from £23.6 billion at the spring forecast. The estimate reflects KPMG’s assessment rather than an official update to the OBR’s forecasts.

    European Stocks Trade Mixed

    European equity markets showed limited movement during the early session.

    Germany’s DAX fell 0.09%, while France’s CAC 40 increased 0.04%.

    The FTSE 100 gained 0.12%, with investors weighing the UK borrowing figures against company-specific developments and international market conditions.

    Sterling was unchanged against the US dollar at $1.3367 at the time of the report.

    Middle East Developments Remain in Focus

    Investors continued to monitor diplomatic developments surrounding Iran as representatives gathered in New York for the United Nations General Assembly.

    Iranian Foreign Minister Abbas Araghchi criticised international institutions ahead of potential discussions with US officials.

    US envoy Mike Waltz indicated that Washington remained open to negotiations with Iran, subject to conditions concerning its participation.

    Iranian President Masoud Pezeshkian also referred to previous agreements that, he said, had not been honoured.

    Separately, G7 foreign ministers called on Iran to end military support for Houthi forces in Yemen, warning about the potential for further regional escalation.

    French President Emmanuel Macron said that discussions with US President Donald Trump had included efforts to reduce tensions in energy markets and maintain freedom of navigation through the Strait of Hormuz.

    The diplomatic developments remained relevant to energy markets because of concerns about potential disruption to oil shipments through the region.

    Oil Prices Rise While Gold Declines

    Oil prices advanced during the session amid continuing uncertainty surrounding Middle East developments.

    Brent crude increased 1.4% to $101.62 a barrel, while West Texas Intermediate (WTI) rose 1% to $93.27.

    Precious metals moved lower, with gold futures declining 0.64% to $4,355.67 an ounce.

    Spot gold fell 0.55% to $4,320.35 an ounce.

    The movements came as investors assessed geopolitical developments alongside the latest economic data.

    UK Company News

    M&C Saatchi Reports Decline in Operating Profit

    M&C Saatchi (LSE:SAA) reported a 31.7% decline in first-half operating profit.

    The advertising group recorded a statutory pre-tax loss, reflecting restructuring costs and weaker revenue from its Middle East operations.

    Smiths Group Operating Profit Exceeds Forecasts

    Smiths Group (LSE:SMIN) reported full-year operating profit ahead of analyst expectations.

    The industrial engineering company also announced that it had launched a process to divest a legacy US asbestos liability associated with its John Crane business.

    The proposed disposal has not yet been completed.

    Kingfisher Upgrades Full-Year Guidance

    Kingfisher (LSE:KGF) raised its full-year guidance following its interim results.

    Growth at Screwfix and in Poland and Iberia supported the home improvement retailer’s performance, although B&Q and Brico Dépôt France reported lower sales.

    The company also reported improved profitability and cash generation during the first half.

    Market Outlook

    UK investors are assessing the implications of higher-than-forecast government borrowing ahead of the Budget, alongside developments in international energy markets.

    The FTSE 100 recorded a modest gain in early trading, while European indices were mixed.

    Corporate earnings remain another focus, with updates from Kingfisher, Smiths Group and M&C Saatchi highlighting differing trading conditions across the retail, industrial engineering and advertising sectors.

    Oil prices and further diplomatic developments in the Middle East could also influence market movements during the session.

  • Cranswick Shares Rise as Berenberg Upgrades Rating and Raises Price Target to 6,080p

    Cranswick Shares Rise as Berenberg Upgrades Rating and Raises Price Target to 6,080p

    Cranswick (LSE:CWK) shares advanced on Tuesday after Berenberg upgraded the food producer to “buy” from “hold” and increased its price target to 6,080 pence from 5,770 pence, citing planned investment in poultry production and its expectations for UK meat demand.

    The shares rose 1.4% to 5,170 pence, their highest level in more than a week, while the FTSE 250 gained 1.18% in the latest available session.

    The broker’s revised assessment followed an investor visit to Cranswick’s poultry facility in Eye, Suffolk, on 15 September.

    Berenberg highlighted the company’s planned capacity expansion and potential for further investment, although it noted that the timing of a proposed second poultry-processing facility remains uncertain.

    Berenberg Raises Price Target to 6,080 Pence

    Berenberg increased its price target for Cranswick to 6,080 pence from 5,770 pence and upgraded its investment rating from “hold” to “buy”.

    The change followed a visit to the company’s Eye poultry-processing facility with investors on 15 September.

    According to Berenberg, the visit demonstrated Cranswick’s position in the poultry market and the potential benefits of additional production capacity.

    The broker cited the company’s investment programme and its expectations for demand growth as factors supporting its revised outlook.

    This was Berenberg’s first rating change for Cranswick in the past 12 months. The broker had previously assigned a “hold” rating and a 5,770-pence price target in November 2025.

    Shares Reach Highest Level in More Than a Week

    Cranswick shares increased 1.4% to 5,170 pence following the upgrade.

    The price represented the stock’s highest level in more than a week.

    The broader FTSE 250 index was up 1.18% during the latest available session.

    The share price movement followed Berenberg’s revised rating and price target, although broader market conditions may also have influenced trading.

    The broker’s new price target represents its assessment of the shares rather than a guaranteed future valuation.

    Eye Poultry Facility Operating at 95% Capacity

    Cranswick’s Eye facility in Suffolk currently processes approximately 1.6 million birds per week.

    The plant is operating at around 95% of its existing capacity.

    The company plans to invest a further £56 million to expand weekly processing capacity to 2 million birds.

    The expansion is expected to be completed by April 2027, followed by a ramp-up period of approximately 12 to 18 months.

    The investment would increase the facility’s processing capacity by 400,000 birds per week once fully implemented.

    The timing of the additional production contribution will depend on completion of the expansion and the subsequent operational ramp-up.

    Poultry and Pork Demand Expected to Increase

    Berenberg expects UK poultry demand to grow by approximately 3% to 4% annually.

    The broker also forecasts annual growth of 1% to 2% in pork demand.

    It said constraints on industry supply could provide opportunities for Cranswick to increase production volumes.

    Berenberg expects the company’s capital investment programme to support volume growth of at least the mid- to high-single-digit range.

    These figures represent the broker’s forecasts and are subject to changes in consumer demand, industry supply and operating conditions.

    The planned expansion at Eye is one of the investments identified by Berenberg as a potential contributor to future production growth.

    Proposed £200 Million Grimsby Facility Remains Subject to Planning

    Berenberg also highlighted Cranswick’s potential development of a second poultry-processing facility near Grimsby.

    The proposed project would involve an investment of approximately £200 million.

    Cranswick has submitted a planning application for the facility, but the timing of the development remains uncertain.

    Berenberg has therefore excluded any contribution from the proposed plant from its financial forecasts.

    The project could provide additional processing capacity if it proceeds, although its development remains dependent on the relevant approvals and investment decisions.

    No construction timetable or expected operational start date was provided in the supplied report.

    Valuation and Earnings Expectations

    Berenberg said Cranswick’s shares were trading at approximately 15.7 times expected FY2027 earnings.

    That compares with a valuation of around 19 times earnings two years earlier.

    The broker linked its revised assessment to Cranswick’s investment programme and the potential for additional production volumes.

    It also identified the company’s returns profile as a factor in its expectations for future earnings growth.

    The valuation multiples and earnings outlook are based on Berenberg’s estimates rather than confirmed future results.

    Outlook

    Cranswick’s planned £56 million expansion at Eye is expected to increase processing capacity from approximately 1.6 million to 2 million birds per week, with completion targeted for April 2027.

    The company anticipates a further 12- to 18-month period to ramp up the expanded facility.

    Berenberg expects growth in UK poultry and pork demand to support the company’s investment plans, while its forecasts exclude the proposed £200 million Grimsby facility because of uncertainty over timing.

    Following its review, the broker raised its price target to 6,080 pence and upgraded its rating to “buy”, with future performance dependent on demand conditions, capacity expansion and the execution of Cranswick’s investment programme.

  • Smiths Group FY2026 Operating Profit Rises 2.7% to £399 Million as Asbestos Liability Disposal Planned

    Smiths Group FY2026 Operating Profit Rises 2.7% to £399 Million as Asbestos Liability Disposal Planned

    Smiths Group (LSE:SMIN) reported headline operating profit of £399 million for the year ended 31 July 2026, exceeding the company-compiled analyst consensus of £388 million, as the industrial engineering group continued to restructure its portfolio.

    Headline operating profit increased 2.7% from £388 million a year earlier, while revenue rose 2.1% to £1.94 billion. Organic revenue growth was 1.2%.

    The company also announced that it had launched a process to divest a legacy US asbestos liability associated with its John Crane business.

    Smiths shares rose more than 5% in early London trading following the announcement.

    Revenue Rises 2.1% to £1.94 Billion

    Smiths Group reported annual revenue of £1.94 billion, representing an increase of 2.1% compared with the previous financial year.

    Organic revenue growth, which excludes the effects of acquisitions, disposals and currency movements, was 1.2%.

    Headline operating profit increased 2.7% to £399 million, ahead of the company-compiled analyst consensus of £388 million.

    The headline operating margin improved to 20.6% from 20.5%, while return on capital employed stood at 23.5%.

    Headline earnings per share rose 6.0% to 86.8 pence.

    On a statutory basis, operating profit declined 16.6% to £289 million, reflecting one-off items associated with the group’s portfolio restructuring.

    The difference between headline and statutory operating profit reflects the impact of these adjustments on the reported results.

    John Crane Records 2.3% Organic Growth

    John Crane, Smiths Group’s industrial engineering business, reported organic revenue growth of 2.3% during FY2026.

    Performance was supported by original equipment sales and activity in the Americas.

    However, the division absorbed an estimated £20 million impact associated with the Middle East conflict.

    The company did not provide further details of the disruption or its potential implications for FY2027 in the supplied announcement.

    John Crane remains a central part of Smiths Group’s industrial engineering operations following the disposal of other businesses.

    Flex-Tek Revenue Declines 0.4% Organically

    Flex-Tek reported a 0.4% decline in organic revenue for the financial year.

    Growth in aerospace was offset by weaker sales in construction and thermal solutions.

    Smiths has been adjusting Flex-Tek’s portfolio through acquisitions and disposals as part of its wider restructuring programme.

    During the year, the company sold three Flex-Tek industrial businesses for £40 million.

    It also acquired DRC HeatTransfer for £165 million, expanding Flex-Tek’s activities into cooling and data centre markets.

    The acquisition forms part of the group’s efforts to develop its remaining industrial engineering businesses.

    Interconnect and Detection Disposals Reach £3.3 Billion

    Smiths Group completed the disposals of its Interconnect and Detection businesses for a combined enterprise value of £3.3 billion.

    The transactions formed part of the company’s strategy to concentrate its operations on industrial engineering.

    The combined disposal value exceeded market expectations, according to the company.

    Smiths also completed the £40 million sale of three Flex-Tek industrial businesses and acquired DRC HeatTransfer for £165 million.

    Chief Executive Roland Carter described FY2026 as a year of significant strategic progress as the company moved towards a more focused industrial engineering portfolio.

    The transactions have changed the composition of the group, with its future financial performance increasingly dependent on its remaining operations.

    Process Launched to Divest US Asbestos Liability

    Smiths Group announced that it had initiated a process to divest a legacy US asbestos liability associated with John Crane.

    The proposed transaction is intended to remove the liability from the group’s balance sheet and reduce earnings volatility.

    The company has not confirmed a buyer, transaction value or completion timetable.

    Any reduction in liabilities and earnings volatility remains conditional on the successful completion of a disposal.

    The announcement represents a further element of Smiths Group’s efforts to simplify its financial and operational structure following its portfolio disposals.

    Net Cash Reaches £1.75 Billion

    Smiths Group ended FY2026 with net cash of £1.75 billion.

    The balance sheet position was strengthened by pension fund transactions during the year.

    The company also progressed its capital return programme, completing £1.5 billion of a planned £3 billion share buyback.

    A further £1.5 billion remains to be returned under the programme.

    The buyback is taking place alongside the group’s restructuring and investment in its remaining businesses.

    Smiths has not specified a completion date for the outstanding share repurchases in the supplied announcement.

    FY2027 Organic Revenue Growth Forecast at Approximately 4%

    Smiths Group expects organic revenue growth of approximately 4% in FY2027.

    The company is also targeting a headline operating margin of around 21% for the financial year.

    The guidance follows FY2026 organic revenue growth of 1.2% and a headline operating margin of 20.6%.

    Smiths reiterated its medium-term targets of 5% to 7% organic revenue growth and a headline operating margin of 21% to 23%.

    These targets reflect management’s expectations for the remaining industrial engineering portfolio following the recent disposals and acquisitions.

    Actual performance will depend on trading conditions, the contribution from the group’s businesses and the execution of its restructuring plans.

    Outlook

    Smiths Group enters FY2027 following the disposal of its Interconnect and Detection businesses, further changes to Flex-Tek’s portfolio and the completion of half of its planned £3 billion share buyback.

    The company expects organic revenue growth of approximately 4% and a headline operating margin of around 21% in the new financial year.

    Management is also pursuing the disposal of John Crane’s legacy US asbestos liability, although the proposed transaction has not yet been completed.

    The group’s medium-term objectives remain organic revenue growth of 5% to 7% and a headline operating margin of 21% to 23%, as it focuses on its remaining industrial engineering operations.

  • MedPal AI: Growth Accelerates as New Health Surges and Fulfilment Capacity Expands

    MedPal AI: Growth Accelerates as New Health Surges and Fulfilment Capacity Expands

    MedPal AI (LSE:MPAL) is moving rapidly from proving demand to building the infrastructure required to support a much larger digital healthcare business, with annualised revenue now exceeding £35 million and New Health continuing to scale at pace.

    In a new ADVFN Watch List interview, Jason Drummond, CEO of MedPal AI, outlined the latest progress across the business, highlighting accelerating customer growth, rising order volumes and a major expansion of the group’s GLP-1 fulfilment capacity.

    The numbers underline just how quickly the business has developed.

    New Health generated £1.8 million of revenue in August, its first full month of marketing, while September is already running more than 35% ahead of August on a daily basis, according to Drummond.

    More than 1.5 million of new orders or order value had already been processed in the first 19 days of September, with more than 12,000 orders recorded during that period.

    The scale of the acceleration is particularly striking when viewed against the original expectations for the New Health launch.

    Drummond said the business had initially prepared for around 300 new orders a day. Instead, MedPal has already reached days where it is dispensing as many as 2,000 orders, representing approximately £300,000 of business in a single day.

    For a business still in the early stages of its commercial rollout, that represents significant operating momentum.

    From zero to more than 25,000 customers

    Customer acquisition is another key part of the story.

    According to Drummond, New Health has grown from zero to more than 25,000 customers since July, with the business focused on combining competitive pricing with clinical support rather than relying on purchased customer acquisition.

    That distinction could become increasingly important as the customer base matures.

    While New Health is still relatively early in its development, Drummond said the business is already seeing customers return for further medication.

    Around 27% of customers are already coming back, he said, despite many having only joined during the second half of August or the beginning of September.

    That creates the potential for repeat orders to build alongside new customer acquisition.

    For a digital healthcare platform, repeat customers can be particularly valuable because the cost of acquiring the original customer does not have to be incurred again for every subsequent order.

    Building capacity for the next stage

    The rapid increase in demand has also created a very different challenge for MedPal: making sure its infrastructure can keep up.

    The company has raised £5 million, predominantly from existing shareholders, with the funding being used in part to expand GLP-1 fulfilment capacity at its Sarus Court facility.

    The scale of the planned upgrade is substantial.

    The more than 20,000 sq ft facility was originally designed to handle approximately 3,000 orders per day. MedPal is now investing just under £1 million into its GLP-1 fulfilment line, taking potential capacity to approximately 14,000 orders per day.

    Drummond expects the expanded facility to be operational by the end of October.

    At maximum capacity, the new line could represent approximately £2 million of order revenue per day, according to management.

    That does not mean MedPal is forecasting revenue at that level. Rather, it illustrates the scale of the infrastructure being put in place to ensure that fulfilment capacity does not become a constraint on future growth.

    Owning the healthcare journey

    Another feature of MedPal’s model is the degree of vertical integration being developed across the business.

    The company operates its own clinic, robotic dispensing, delivery infrastructure and technology platform.

    Drummond argues that automation across the chain can reduce both cost and friction while allowing MedPal to maintain competitive pricing and clinical support.

    That infrastructure is becoming increasingly important as the business moves from an early-stage growth story towards a potentially much larger healthcare platform.

    There is also a significant working-capital component to rapid growth.

    MedPal has to pay for medication before it is delivered, while payments from the NHS and other counterparties arrive later. As volumes increase, the amount of working capital required to bridge that timing difference also increases.

    The latest £5 million raise therefore provides not only investment capital for additional fulfilment capacity, but also additional resources to support the working-capital requirements associated with a rapidly expanding business.

    Growth rather than braking

    Perhaps the clearest message from the interview is that MedPal is now focused on matching infrastructure with demand rather than slowing growth to fit existing capacity.

    Drummond said existing shareholders had effectively encouraged the company to “keep this thing going”, with management now looking to expand the business and capture the demand it is seeing.

    The company is also in discussions with major UK clearing banks regarding facilities to support the working-capital requirements of the expanding operation.

    That is an important development as MedPal moves into its next phase.

    The business has gone from zero to more than £35 million of annualised revenue in just 11 months, according to Drummond, while New Health has rapidly established a growing customer base and significant order volumes.

    With additional fulfilment capacity expected by the end of October, the focus now shifts towards how quickly MedPal can scale the platform while maintaining service levels, customer retention and operational efficiency.

    For investors following the MedPal story, the latest update provides a clear indication of the company’s current priorities: convert accelerating demand into recurring revenue, expand fulfilment capacity and build the infrastructure required to support the next stage of growth.

    With New Health still in the early stages of its rollout and the new GLP-1 fulfilment line set to materially increase capacity, MedPal AI is entering an important phase in its development.

    The challenge is no longer simply demonstrating demand — it is building enough capacity to meet it.

    For more information visit – https://medpal.co/

  • Oxford Biomedica H1 Revenue Reaches £80.2 Million as FY2026 Guidance Maintained

    Oxford Biomedica H1 Revenue Reaches £80.2 Million as FY2026 Guidance Maintained

    Oxford Biomedica (LSE:OXB) reported revenue of £80.2 million for the first half of 2026, representing a 10% increase on a constant-currency basis, supported by demand for its development and manufacturing services.

    The cell and gene therapy contract development and manufacturing organisation (CDMO) secured a record 17 new clients during the period and reported a revenue backlog of approximately £193 million.

    Gross margin declined to 37%, while the company recorded a small operating EBITDA loss. Adjusted EBITDA nevertheless improved compared with the corresponding period last year.

    Oxford Biomedica reiterated its full-year revenue guidance of £180 million to £200 million and confirmed that GMP manufacturing operations at its Durham facility in North Carolina are now operational.

    Revenue Increases 10% on a Constant-Currency Basis

    Oxford Biomedica generated revenue of £80.2 million during the first six months of 2026, an increase of 10% at constant currency.

    Growth was supported by demand for the company’s development and manufacturing services, which are used by customers developing cell and gene therapies.

    The company provides viral vector development and manufacturing services across several technologies, including lentiviral, adeno-associated viral and adenoviral vectors.

    Its services cover multiple stages of development, from early research and clinical programmes through to commercial manufacturing.

    The supplied announcement does not provide the reported-currency revenue growth rate or a breakdown of revenue by service category.

    Record 17 New Clients Secured

    Oxford Biomedica reported 17 new client wins during the first half, a record for the company.

    The additions form part of its strategy to expand and diversify its customer base.

    The company provides outsourced development and manufacturing services to organisations working on cell and gene therapies.

    New client relationships may involve development work, manufacturing services or programmes that progress through different stages of clinical and commercial development.

    The supplied announcement does not disclose the value of the new contracts or specify their expected contribution to revenue.

    Gross Margin Declines to 37%

    Oxford Biomedica reported a gross margin of 37% for the first half of 2026, reflecting a reduction compared with the previous period.

    The company also recorded a small operating EBITDA loss.

    Adjusted EBITDA improved year on year, supported by continued cost discipline.

    The supplied announcement does not provide the precise operating EBITDA loss, adjusted EBITDA figure or comparative gross margin.

    The difference between operating EBITDA and adjusted EBITDA should be considered when assessing the company’s underlying profitability.

    Oxford Biomedica continues to manage its cost base while expanding its manufacturing capacity and customer relationships.

    Durham Manufacturing Facility Begins GMP Operations

    Oxford Biomedica confirmed that good manufacturing practice (GMP) manufacturing operations at its Durham facility in North Carolina are now operational.

    The site expands the company’s manufacturing presence in the United States and complements its existing facilities in the UK, France and Bedford, Massachusetts.

    The additional capacity forms part of Oxford Biomedica’s international manufacturing network.

    The company is developing its global operations to serve customers across different stages of cell and gene therapy development and manufacturing.

    The supplied announcement does not specify the Durham facility’s production capacity or expected revenue contribution.

    Revenue Backlog Reaches Approximately £193 Million

    Oxford Biomedica reported a revenue backlog of approximately £193 million at the end of the first half.

    The company also indicated that a substantial proportion of its expected 2026 revenue is covered by existing contracts.

    The backlog provides visibility over future contracted work, although the timing of revenue recognition will depend on project delivery and contractual arrangements.

    The company has not disclosed the precise percentage of full-year revenue covered by contracts or the expected conversion schedule for the backlog.

    The combination of existing contracted work and new client wins supports management’s decision to maintain its full-year revenue expectations.

    FY2026 Revenue Guidance Maintained at £180 Million to £200 Million

    Oxford Biomedica reiterated its guidance for full-year 2026 revenue of between £180 million and £200 million.

    The company cited its contracted revenue coverage and existing backlog alongside continued demand for development and manufacturing services.

    The guidance remains unchanged following first-half revenue of £80.2 million.

    Oxford Biomedica continues to focus on customer acquisition, delivery of contracted programmes and the expansion of its manufacturing network.

    Actual full-year performance will depend on the timing and execution of customer projects and the recognition of associated revenue.

    Long-Term Revenue Ambition of Approximately £500 Million

    Oxford Biomedica continues to target annual revenue of approximately £500 million by 2030.

    The ambition is supported by its plans to expand its customer base, develop its manufacturing capabilities and increase the scale of its global operations.

    The company operates facilities in the UK, France and the United States, with the Durham site now providing additional GMP manufacturing capacity.

    The £500 million figure is a longer-term management objective rather than a confirmed revenue outcome.

    Progress towards that target will depend on customer demand, contract execution and the company’s ability to expand its services and operations.

    Outlook

    Oxford Biomedica enters the second half of 2026 with revenue of £80.2 million, a backlog of approximately £193 million and a record 17 new client wins during the first half.

    The company has maintained its full-year revenue guidance of £180 million to £200 million, supported by existing contracted work.

    Its priorities include delivering customer programmes, developing its international manufacturing operations and expanding its client base.

    Management continues to pursue its longer-term objective of approximately £500 million in annual revenue by 2030, while maintaining cost discipline following the first-half decline in gross margin.

  • Fonix FY2026 Gross Profit Rises 12.9% to £21 Million as European Expansion Continues

    Fonix FY2026 Gross Profit Rises 12.9% to £21 Million as European Expansion Continues

    Fonix plc (LSE:FNX) reported a 12.9% increase in gross profit to £21.0 million for the financial year ended 30 June 2026, supported by its existing mobile payments business, international expansion and the introduction of new products.

    Adjusted EBITDA rose 11.0% to £16.2 million, while adjusted earnings per share increased 7.1%.

    The mobile payments and messaging provider increased its ordinary dividend to 9.30 pence per share and completed £2.4 million of share buybacks during the year.

    Fonix also reported progress across several European markets, expanded the availability of its PayFlex platform and renewed contracts with major UK and Irish media customers.

    Gross Profit Increases 12.9% to £21 Million

    Fonix reported gross profit of £21.0 million for FY2026, representing growth of 12.9% compared with the previous financial year.

    Adjusted EBITDA increased 11.0% to £16.2 million, while adjusted earnings per share rose 7.1%.

    The results marked a return to double-digit growth in gross profit and adjusted EBITDA.

    The company maintained a strong cash position while continuing to invest in international expansion and product development.

    Fonix operates an asset-light business model, providing mobile payment and messaging services to customers in the media, charity, entertainment and enterprise sectors.

    The supplied announcement does not disclose the company’s total revenue or year-end cash balance.

    Dividend Rises to 9.30 Pence Per Share

    Fonix increased its ordinary dividend to 9.30 pence per share for FY2026.

    The company also completed £2.4 million of share buybacks during the financial year.

    These shareholder distributions accompanied an increase in adjusted EBITDA and adjusted earnings per share.

    Fonix continued to invest in its technology platform and international operations during the period.

    The company has not specified the percentage increase in its ordinary dividend in the supplied announcement.

    Portugal Established as Third Market

    Fonix reported progress in implementing its international expansion strategy during FY2026.

    Portugal is now established as the group’s third market, extending its operations beyond the UK and Ireland.

    The company has also launched services in Switzerland, where it is working with two broadcast customers.

    In France, Fonix has established the staffing and organisational structure needed to support further expansion.

    The group is seeking to apply its existing technology platform across additional European markets rather than developing separate systems for each country.

    Sixth European Market Targeted for FY2027 Launch

    Fonix completed network connectivity in a sixth European market during the financial year.

    The company is targeting a launch in that market towards the end of FY2027.

    The market has not been identified in the supplied announcement.

    Fonix’s international strategy involves expanding the availability of its mobile payments and messaging services through a common platform.

    The company expects its international operations to contribute to future growth, although the timing and scale of revenue generation will depend on customer adoption and commercial activity in each market.

    PayFlex Expands to Major Customers

    Fonix continued the commercial rollout of PayFlex during FY2026.

    The product was introduced to major customers, including its first client outside the UK.

    The expansion represents a further step in making Fonix’s existing services available across its international operations.

    The company has not disclosed the number of PayFlex customers added during the year or the revenue generated by the product.

    Fonix intends to develop its product portfolio alongside its geographic expansion, providing additional services to both existing and new customers.

    CompsPortal Launches With Channel 5

    Fonix launched CompsPortal with Channel 5 during the financial year.

    The product also received a national technology award.

    CompsPortal forms part of the group’s broader offering for media customers, alongside its established mobile payment and messaging services.

    Fonix continues to develop products intended to support audience participation and digital engagement.

    The company has not provided separate revenue or profit figures for CompsPortal in the supplied announcement.

    RichMessaging Trials Progress

    Fonix conducted trials of its RichMessaging products during FY2026.

    The company reported encouraging results and plans to convert the trial activity into recurring customer campaigns.

    RichMessaging is part of Fonix’s wider product development programme, which aims to expand the services available through its technology platform.

    The company has not disclosed the number of trials completed, their financial contribution or the value of potential future campaigns.

    Further commercial progress will depend on customers adopting the service for repeat use.

    Major Media Contracts Renewed and Extended

    Fonix renewed or extended long-term agreements with key media customers in the UK and Ireland during the year.

    These included contracts involving Global’s radio brands and ITV’s flagship programmes.

    The agreements provide continued access to established customers as Fonix develops its international business and introduces additional products.

    The group serves a range of media and charitable organisations, including ITV, Bauer Media, RTÉ, Global, Comic Relief and BBC Children in Need.

    The supplied announcement does not disclose the financial value or specific duration of the renewed contracts.

    Outlook

    Fonix expects further profitable growth in FY2027, supported by its established UK and Irish operations, international expansion and new product launches.

    The company plans to develop its activities in Portugal, Switzerland and France while preparing for the launch of a sixth European market towards the end of the financial year.

    Management also intends to expand the use of PayFlex and CompsPortal and convert RichMessaging trials into repeat campaigns.

    Fonix enters FY2027 following a 12.9% increase in gross profit to £21.0 million and an 11.0% rise in adjusted EBITDA to £16.2 million, alongside an increased ordinary dividend and £2.4 million of share buybacks.

  • Kingfisher H1 Adjusted Pre-Tax Profit Rises 9.9% to £404 Million as Full-Year Guidance Upgraded

    Kingfisher H1 Adjusted Pre-Tax Profit Rises 9.9% to £404 Million as Full-Year Guidance Upgraded

    Kingfisher (LSE:KGF) reported a 9.9% increase in adjusted pre-tax profit to £404 million for the six months ended 31 July 2026, supported by improved gross margins, higher customer transactions and cost control.

    The home improvement retailer recorded a 1.6% increase in total sales including marketplace activity, while like-for-like sales rose slightly. Screwfix, Poland and Iberia were among the main contributors to growth.

    Gross margin improved by 70 basis points, and adjusted earnings per share increased 16.1%. The company also generated £339 million in free cash flow.

    Following the first-half results, Kingfisher upgraded its full-year guidance for adjusted pre-tax profit and free cash flow, maintained its interim dividend and continued its £300 million share buyback programme.

    Sales Increase 1.6% as Customer Transactions Rise

    Kingfisher reported a 1.6% increase in total sales including marketplace activity during the first half of its financial year.

    Like-for-like sales also increased slightly, supported by higher customer transaction volumes.

    The group identified Screwfix, Poland and Iberia as areas of particular growth during the period.

    Kingfisher operates home improvement retail brands including B&Q, Screwfix, Castorama and Brico Dépôt across the UK, Ireland, France, Poland and Iberia.

    The company continues to serve both trade professionals and DIY customers through its stores, digital platforms and marketplace operations.

    Adjusted Pre-Tax Profit Reaches £404 Million

    Adjusted pre-tax profit increased 9.9% to £404 million for the six-month period.

    Gross margin expanded by 70 basis points, while adjusted earnings per share rose 16.1%.

    The improvement in profitability reflected a combination of sales growth, cost control and a one-off business rates refund.

    Ongoing share buybacks also supported adjusted earnings per share.

    The business rates refund was a non-recurring benefit, meaning its contribution should be distinguished from the performance of the group’s underlying retail operations.

    The supplied announcement does not provide the value of the refund or a profit figure excluding its impact.

    Screwfix, Poland and Iberia Support Growth

    Kingfisher reported growth at Screwfix and across its businesses in Poland and Iberia during the first half.

    The performance contributed to the group’s increase in total sales and helped offset differences in trading conditions across its retail markets.

    Screwfix forms a central part of Kingfisher’s trade-focused operations, while the group also serves professional customers through its other retail brands.

    The company reported market share gains during the period, although the supplied announcement does not provide individual market share figures for each country or business.

    Kingfisher continues to develop its retail operations across its European markets while expanding services for trade customers.

    Trade Sales Penetration Reaches 31%

    Trade sales accounted for 31% of Kingfisher’s sales during the first half, reflecting the group’s continued focus on professional customers.

    The company has been expanding its trade offering across its retail brands, including Screwfix and its other home improvement businesses.

    Kingfisher also reported increased activity through its digital channels.

    Online penetration reached 22%, highlighting the contribution of e-commerce to the group’s overall sales mix.

    The retailer continues to develop its digital operations, marketplace services and retail media activities alongside its physical store network.

    Free Cash Flow Reaches £339 Million

    Kingfisher generated £339 million in free cash flow during the six months ended 31 July 2026.

    The company reported the cash generation alongside its increase in adjusted pre-tax profit and improvement in gross margin.

    Following the interim results, Kingfisher raised its full-year free cash flow guidance.

    The supplied announcement does not specify the revised cash flow target or provide a comparative first-half figure.

    Free cash flow remains relevant to the group’s investment plans and shareholder distributions, including dividends and share buybacks.

    Interim Dividend Maintained at 3.8 Pence

    Kingfisher maintained its interim dividend at 3.8 pence per share.

    The group is also progressing a £300 million share buyback programme.

    Share repurchases contributed to the increase in adjusted earnings per share during the first half, alongside the improvement in profitability.

    The company continues to return capital to shareholders while investing in its retail and digital operations.

    The supplied announcement does not specify how much of the £300 million buyback programme has been completed.

    Full-Year Profit and Cash Flow Guidance Upgraded

    Kingfisher upgraded its full-year expectations for adjusted pre-tax profit and free cash flow following the first-half performance.

    The revised outlook reflects the group’s sales performance, gross margin improvement and cash generation during the period.

    The company reported higher customer transactions, growth in its trade and digital channels, and market share gains across its operations.

    However, the supplied announcement does not include the revised numerical guidance ranges.

    The contribution from the one-off business rates refund should also be considered when assessing the relationship between first-half profitability and the group’s underlying performance.

    Outlook

    Kingfisher enters the second half of its financial year with upgraded guidance for adjusted pre-tax profit and free cash flow.

    The group continues to focus on expanding its trade customer offering, developing its e-commerce and marketplace activities, and managing operating costs.

    Its first-half results included a 1.6% increase in total sales including marketplace activity, adjusted pre-tax profit of £404 million and free cash flow of £339 million.

    Kingfisher has maintained its interim dividend at 3.8 pence per share and is continuing its £300 million share buyback programme.